Your session is about to expire
← Back to Search
pHRMi for Swallowing Difficulty
N/A
Waitlist Available
Led By Harry Quon, MD
Research Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months 9 months
Awards & highlights
Study Summary
This trial is examining whether using a machine to measure changes in the swallow function of head and neck cancer patients treated with radiotherapy can help identify biomechanical changes.
Eligible Conditions
- Swallowing Difficulty
- Head and Neck Cancers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months 9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in swallowing function as assessed by serial pHRMi
Secondary outcome measures
Change in peak flow swallow measures
Trial Design
1Treatment groups
Experimental Treatment
Group I: pHRMi in evaluation of swallowing functionExperimental Treatment1 Intervention
Pharyngeal High Resolution Manometry and Impedance (pHRMi) evaluation of swallowing function at baseline, 3 months post radiation, then at 9 months
Find a Location
Who is running the clinical trial?
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
557 Previous Clinical Trials
32,900 Total Patients Enrolled
Harry Quon, MDPrincipal InvestigatorSKCCC at Johns Hopkins (East Baltimore Campus)
2 Previous Clinical Trials
51 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
For whom would this research program be a suitable option?
"This investigation is looking for 40 individuals aged between 18 and 100 with dysphagia. Most significantly, they must meet the following criteria: Having untreated head and neck cancer of any type which will receive radiation as part of their curative oncological plan; this can include concurrent chemotherapy or not./ They may have undergone prior surgery to treat HNC or not."
Answered by AI
Share this study with friends
Copy Link
Messenger